News

Zacks Investment Research on MSN13h
Lilly Down 17% Since Q1 Results: Should You Buy the Dip in LLY Stock?
Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed ...
Vanda Pharmaceuticals Inc.: Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results
Fanapt® Q1 2025 total prescriptions (TRx) increased 14% compared to Q1 2024 Fanapt® Q1 2025 new to brand prescriptions (NBRx) increased nearly threefold compared to Q1 2024 Bysanti ...
Veru Inc.: Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...